Patients with an incurable blood cancer – polycythaemia vera (PV) – may respond better to a new drug compared to conventional best treatment, a new clinical trial has found. The rare cancer resu…

Birmingham Health Partners has underlined its commitment to delivering research that enhances health and wellbeing by welcoming Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT) a…

Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at BHP…

Children with some solid tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at the American Association of Cancer Research’s Ann…

The Universities of Birmingham and Aston – both BHP members – are to participate in the West Midlands Innovation Accelerator announced this week by the West Midlands Combined Authority.Designed to …

Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has called for greater engagement with clinicians and a deeper understanding of patient experience when considering t…